William Enright
2023
In 2023, William Enright earned a total compensation of $1.8M as Chief Executive Officer at Barinthus Biotherapeutics plc., a 13% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $307,989 |
---|---|
Option Awards | $842,168 |
Salary | $610,000 |
Other | $51,454 |
Total | $1,811,611 |
Enright received $842.2K in option awards, accounting for 46% of the total pay in 2023.
Enright also received $308K in non-equity incentive plan, $610K in salary and $51.5K in other compensation.
Rankings
In 2023, William Enright's compensation ranked 608th out of 3,006 executives tracked by ExecPay. In other words, Enright earned more than 79.8% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 608 out of 3,006 | 80th |
Division Manufacturing | 342 out of 1,650 | 79th |
Major group Chemicals And Allied Products | 236 out of 918 | 74th |
Industry group Drugs | 232 out of 881 | 74th |
Industry Pharmaceutical Preparations | 147 out of 637 | 77th |
Source: SEC filing on March 22, 2024.
Enright's colleagues
We found two more compensation records of executives who worked with William Enright at Barinthus Biotherapeutics plc. in 2023.